Back to Search
WILLIAM KELLY, MD
MD
Anesthesiology Physician
NPI: 1598076580IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
TL-3702(CO)
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
53603(CO)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Class of 2010
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Protein-protein interactions: from global to local analyses.
PMID 18644446·Curr Opin Biotechnol·2008
6-review
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
PMID 18989865·Cancer·2008
3-trial
Guidelines for submitting adverse event reports for publication.
PMID 17471601·Pharmacoepidemiol Drug Saf·2007
6-review
Characterization of the aminocarboxycyclopropane-forming enzyme CmaC.
PMID 17209546·Biochemistry·2007
8-other
Compelling features of a safe medication-use system.
PMID 16849713·Am J Health Syst Pharm·2006
8-other
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.
PMID 15897550·J Clin Oncol·2005
3-trial
Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid.
PMID 16264908·Nat Clin Pract Oncol·2005
6-review
Excision of the epothilone synthetase B cyclization domain and demonstration of in trans condensation/cyclodehydration activity.
PMID 16201763·Biochemistry·2005
8-other
Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.
PMID 16010459·Pituitary·2004
8-other
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
PMID 14506144·Clin Cancer Res·2003
3-trial
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
PMID 12796374·Clin Cancer Res·2003
3-trial
Worry and sleep length revisited: worry, sleep length, and sleep disturbance ascribed to worry.
PMID 12230151·J Genet Psychol·2002
8-other
Anxiety and the prediction of task duration: a preliminary analysis.
PMID 12022778·J Psychol·2002
8-other
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.
PMID 11134194·J Clin Oncol·2001
3-trial
Chemotherapy for androgen- independent prostate cancer: myth or reality.
PMID 11122870·Curr Oncol Rep·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 8101 E LOWRY BLVD STE 120
DENVER, CO 80230 - Phone
- (303) 909-4157
Quick Facts
- NPI
- 1598076580
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 16
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile